PharmaCielo Ltd.
PCLO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.59M | -3.31M | -4.67M | -5.61M | -6.55M |
| Total Depreciation and Amortization | 1.01M | 691.20K | 583.20K | 704.50K | 941.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -441.00K | 2.31M | 2.86M | 3.36M | 3.80M |
| Change in Net Operating Assets | -1.32M | -575.80K | -174.90K | 2.30M | 587.30K |
| Cash from Operations | -3.33M | -885.70K | -1.40M | 753.00K | -1.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 7.25M | 4.84M | 5.38M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 22.90K | 22.90K | 22.90K | 22.90K |
| Cash from Investing | 7.25M | 4.86M | 5.40M | 22.90K | 22.90K |
| Total Debt Issued | 415.00K | 705.00K | 1.07M | 1.66M | 2.39M |
| Total Debt Repaid | -5.85M | -5.94M | -6.24M | -2.64M | -742.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.94M | -3.81M | -3.76M | -718.80K | 1.19M |
| Foreign Exchange rate Adjustments | 1.90K | 17.40K | 12.30K | 1.60K | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.90K | 186.40K | 250.60K | 58.60K | -7.50K |